Analysis of Cytokine Profiles in Pediatric Myocarditis Multicenter Study

Yoji Nomura1, Takanori Suzuki2,3, Katsuyuki Kunida4

  • 1Department of Pediatric Cardiology, Aichi Children's Health and Medical Center, Aichi, Japan.

Pediatric Cardiology
|March 14, 2024
PubMed

Insights

Cytokine profiles can distinguish severe pediatric fulminant myocarditis (FM) from acute myocarditis (AM). Specific cytokine levels may help predict disease severity and guide targeted therapies for myocarditis in children.

Area of Science:

  • Pediatric Cardiology
  • Immunology
  • Molecular Biology

Background:

  • Acute myocarditis (AM) is an inflammatory heart condition that can progress to severe, life-threatening fulminant myocarditis (FM).
  • Understanding the cytokine profiles in pediatric myocarditis, particularly in relation to FM, is crucial for diagnosis and treatment.
  • Current knowledge on cytokine differences between pediatric AM and FM is limited.

Purpose of the Study:

  • To evaluate and compare the cytokine profiles of pediatric patients with acute myocarditis (AM) and fulminant myocarditis (FM).
  • To identify specific cytokines that can differentiate between AM and FM in children.
  • To explore the potential of cytokine profiles for disease stratification and prognosis prediction.

Main Methods:

  • A cohort of pediatric patients diagnosed with AM or FM was studied.
  • Cytokine levels were quantified using a multiplexed fluorescent bead-based immunoassay.
  • Statistical analyses, including Principal Component Analysis (PCA), were employed to compare cytokine levels between FM, AM, and healthy control (HC) groups.

Main Results:

  • Four cytokines (IL-1RA, IL-8, IL-10, IL-15) were significantly elevated in the FM group compared to the AM group.
  • Interleukin-4 (IL-4) was significantly higher in the AM group than in both FM and HC groups.
  • Platelet-Derived Growth Factor-AA (PDGF-AA) and Vascular Endothelial Growth Factor-A (VEGF-A) were significantly lower in the FM group than in the AM group.

Conclusions:

  • Distinct cytokine profiles exist between pediatric fulminant myocarditis (FM) and acute myocarditis (AM).
  • Cytokine analysis may serve as a valuable tool for differentiating FM from AM, assessing disease severity, and predicting patient outcomes.
  • Targeted therapies focusing on individual cytokines hold potential for managing myocarditis and preventing progression to FM, warranting further investigation.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...